文献速递肿瘤 PET/CT

数字PET与高分辨率常规PET在癌症患者中的表现比较

Performance of Digital PET Compared with High-Resolution Conventional PET in Patients with Cancer.
PubMed 文献 · J Nucl Med · 2020-02-14

该前瞻性研究纳入66例癌症患者,单次注射18F-FDG后随机顺序行数字PET(dPET)与高分辨率常规PET(cPET)显像。dPET较cPET提高了SUVmean、SUVmax和病灶-本底比,降低了代谢肿瘤体积,检出更多cPET上不可测或不可见的小病灶,并在30例初始分期患者中使13%的患者TNM分期上调。dPET图像质量评分更高且在多数病例中被视觉优先选择,作者认为需更多研究确认其诊断优势。

要点

  • dPET较cPET使SUVmean、SUVmax和病灶-本底比分别升高24%、23%和27%(P < 0.001),代谢肿瘤体积降低13%(P < 0.001)。
  • 27例患者中dPET额外发现37个病灶(41%),其中14个在cPET上不可测、23个不可见。
  • 30例初始分期患者中dPET使13%(4/30)TNM分期上调,图像质量评分更高(P = 0.003),65%病例视觉优先选择dPET。

核心结论

  • dPET改善了小病灶的检测,使疾病分期上调,并产生较HR cPET视觉更优的图像。
  • 作者认为需要更多研究来确认dPET的优越诊断性能。

研究设计与样本

  • 前瞻性研究,66例癌症患者单次注射18F-FDG后以随机顺序行dPET与cPET显像。
  • 两种扫描仪均采用高分辨率重建(2 × 2 × 2 mm体素),每例患者最多分析5个18F-FDG阳性病灶。
  • 由两名核医学专家以盲法对30例初始分期患者从两套图像判定TNM评分,并对全部66例患者独立评估图像质量(4分制)及扫描偏好。

主要发现

  • 共纳入238个在两种PET上均可见且可测的病灶。
  • 27例患者中dPET额外发现37个病灶(41%),其中14个在cPET上不可测、23个不可见。
  • cPET的SUVmean、SUVmax、病灶-本底比和代谢肿瘤体积均值(±SD)分别为5.2 ± 3.9、6.9 ± 5.6、5.0 ± 3.6和2,991 ± 13,251 mm3。
  • dPET较cPET的SUVmean、SUVmax和病灶-本底比分别升高24%、23%和27%(P < 0.001),代谢肿瘤体积降低13%(P < 0.001)。
  • 视觉分析显示dPET使13%(4/30)的患者TNM分期上调;dPET图像质量评分更高(P = 0.003),在大多数病例中视觉优先选择dPET(65%)。

关键数值与推荐

  • 两种扫描仪均采用高分辨率重建,体素为2 × 2 × 2 mm。
  • 图像质量采用4分制评估,并记录扫描偏好。
  • dPET较cPET的SUVmean升高24%、SUVmax升高23%、病灶-本底比升高27%(P < 0.001),代谢肿瘤体积降低13%(P < 0.001)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 作者结论指出需要更多研究来确认dPET的优越诊断性能。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Recently introduced PET systems using silicon photomultipliers with digital readout (dPET) have an improved timing and spatial resolution, aiming at a better image quality than conventional PET (cPET) systems. We prospectively evaluated the performance of a dPET system in patients with cancer, as compared with high-resolution (HR) cPET imaging. Methods: After a single 18F-FDG injection, 66 patients underwent dPET and cPET imaging in randomized order. We used HR reconstructions (2 × 2 × 2 mm voxels) for both scanners and determined SUVmax, SUVmean, lesion-to-background ratio (LBR), metabolic tumor volume (MTV), and lesion diameter in up to 5 18F-FDG-positive lesions per patient. Furthermore, we counted the number of visible and measurable lesions on each PET scan. Two nuclear medicine specialists determined, in a masked manner, the TNM score from both image sets in 30 patients referred for initial staging. For all 66 patients, these specialists separately evaluated image quality (4-point scale) and determined the scan preference. Results: We included 238 lesions that were visible and measurable on both PET scans. For 27 patients, we found 37 additional lesions on dPET (41%) that were unmeasurable (n = 14) or invisible (n = 23) on cPET. Mean (±SD) SUVmean, SUVmax, LBR, and MTV on cPET were 5.2 ± 3.9, 6.9 ± 5.6, 5.0 ± 3.6, and 2,991 ± 13,251 mm3, respectively. On dPET, SUVmean, SUVmax, and LBR increased by 24%, 23%, and 27%, respectively (P < 0.001) whereas MTV decreased by 13% (P < 0.001), compared with cPET. Visual analysis showed TNM upstaging with dPET in 13% of the patients (4/30). dPET images also had higher scores for quality (P = 0.003) and were visually preferred in most cases (65%). Conclusion: dPET improved the detection of small lesions, upstaged the disease, and produced images that were visually preferred to those from HR cPET. More studies are necessary to confirm the superior diagnostic performance of dPET.Keywords: digital PET; conventional PET; FDG PET; lesion detection; cancer imaging.

来源:J Nucl Med,查看原文。版权归原作者所有。

引用

  1. Koopman D, van Dalen JA, Stevens H, et al. Performance of Digital PET Compared with High-Resolution Conventional PET in Patients with Cancer. J Nucl Med. 2020. PMID: 32060217. doi:10.2967/jnumed.119.238105

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。